The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $137,200.00 firm fixed-price purchase order to Cardiodynamics B.V., doing business as CD Leycom, for the CD LEYCOM INCA PRESSURE VOLUME LOOP SYSTEM. The contract, which has a completion date of June 6, 2024, is for the provision of medical equipment, specifically cardiac and hemodynamic analysis systems. CD Leycom, a for-profit organization, has a history of providing...
<p>The National Heart Lung and Blood Institute (NHLBI), a civilian agency, has awarded a $29,740.00 firm fixed price purchase order contract to Applied Photophysics Inc. for a Q100 CD Spectrometer Service Agreement. The contract has a performance period ending on July 15, 2025. This contract is not set aside for any small business designation.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Philips Medical Systems North America Inc. valued at $3,468.00 on May 13, 2011, for maintenance and repair of instruments and laboratory equipment. Place of performance is Bethesda, Maryland. The order carries firm fixed price pricing with no set-aside designation. Ultimate completion date is May 21, 2012.</p>
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, issued a delivery order to Computer Packages Inc. on September 23, 2018, with a ceiling value of $44,894.00 for payment of NHLBI patent maintenance and annuity fees in the United States and foreign countries. The order is issued under Computer Packages Inc.'s Indefinite Delivery Contract with the NIH Office of Logistics and Acquisition Operations. Place of performance is Rockville, MD. The order...
<p>The National Heart Lung and Blood Institute issued a $15,213 delivery order to Beckman Coulter, Inc. on April 22, 2024, for instrument service contract support to maintain biophysics core lab equipment at the NIH NHLBI facility in Brea, California. The order is firm fixed price with an ultimate completion date of April 21, 2025.</p>
<p>The National Heart, Lung and Blood Institute (NHLBI) awarded a purchase order to Advarra, Inc. for $30,150.00 on June 1, 2026. The order covers investigational device and investigational new drug protocol reviews by external institutional review board for multi-site studies on a severable basis. Performance occurs in Bethesda, Maryland, with an ultimate completion date of May 31, 2027. Pricing is firm fixed price.</p>
The National Heart, Lung, and Blood Institute issued a $53,413 delivery order to Computer Packages Inc. on May 7, 2019, for payment of NHLBI patent maintenance and annuity fees in the United States and foreign countries. The order was issued under a single-award Indefinite Delivery Contract with the NIH Office of Logistics and Acquisition Operations. Place of performance is Rockville, MD. The delivery order carries a firm fixed-price structure with an ultimate completion date of September 16,...
<p>The National Heart Lung and Blood Institute awarded a purchase order to Oak Ridge Associated Universities, Incorporated for $67,645.02 on December 23, 2015. The order calls for scientific support services to the NHLBI Division of Intramural Research over a one-year period of performance, with an ultimate completion date of September 7, 2017. Work is performed at Bethesda, Maryland. The contract is fixed-price with no set-aside applied.</p>
<p>The National Heart, Lung, and Blood Institute (NHLBI) issued a purchase order to Corstem Inc. for $100,000.00 on September 26, 2017, for professional support services to the NHLBI Division of Intramural Research. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and concludes September 25, 2018.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Philips Medical Systems North America Inc. for $29,760.00 on January 13, 2011, for maintenance and repair of instruments and laboratory equipment, with completion by December 31, 2011. Work is performed in Bethesda, Maryland. The order carries firm fixed price pricing under full-and-open competition with no set-aside designation.</p>